C oronary computed tomography angiography (CTA) allows direct noninvasive assessment of coronary artery disease, over the coronary artery tree. [1] [2] [3] [4] [5] In addition to luminal stenosis, CTA also permits assessment of atherosclerotic plaque, including plaque burden, distribution, and composition, and coronary artery remodeling, previously only achievable through invasive means. 6-10 Impaired myocardial flow reserve (MFR), defined as the ratio of hyperemic myocardial blood flow to that at rest, is known as an imaging marker of prognostic importance. [11] [12] [13] [14] The aim of this study was to investigate whether the automated measurements of coronary plaque burden can predict coronary vascular dysfunction by impaired MFR measured by 13 N-Ammonia positron emission tomography (PET), and further, to evaluate the feasibility of an objective machine-learning approach to predict coronary vascular dysfunction by combining multiple quantitative plaque features from CTA.
Plaque and Impaired Myocardial Flow Reserve

Methods Patients
The study sample consisted of consecutive patients with suspected coronary artery disease referred for combined noninvasive evaluation of myocardial perfusion by rest-stress 13 N-Ammonia PET and anatomic coronary evaluation by CTA from July 2010 to October 2012. Patients with known hypersensitivity to β-blockers and iodinated contrast agents, patients with renal failure (serum creatinine level >1.2 mg/dL), and patients with contraindications for adenosine administration were excluded from imaging. Sixty-six patients were referred for combined PET myocardial perfusion imaging and CTA. Eight patients had coronary stents and were excluded for quantitative plaque analysis. Furthermore, 7 patients had significant motion artifacts on CTA because of which at least 1 coronary artery was judged to have nonevaluable segments. These patients were excluded from analysis. Our study included 51 patients (32 men; age, 62.4±9.5 years). Table 1 shows the characteristics of the patients in this study. The study was approved by the Institutional Review Board.
Hybrid PET/CT Acquisition and Reconstruction
All images were acquired on a whole body 64-slice PET/CT scanner (Biograph True Point; Siemens Medical Solutions). PET data were acquired in 3-dimensional (3D) list mode. Patients were studied after an overnight fast, and all refrained from caffeine-containing beverages or theophylline-containing medications for 24 hours before the study. Myocardial perfusion was assessed at rest and during vasodilator stress with adenosine and 13 N-Ammonia as a perfusion radiotracer. Two CT-based transmission scans (120 kVp; 20-30 mA; helical scan mode with a pitch of 1.35) were obtained before the rest perfusion studies and after the stress perfusion studies with normal breathing, for correction of photon attenuation for PET. The registration of the CT attenuation map with the PET images was verified visually by an experienced technologist, and alignment was corrected if necessary by manual 3D translation. Regional myocardial perfusion was first assessed during rest using 740 MBq of 13 N-Ammonia. Rest imaging extended for 10 minutes and began a few seconds before the 13 N-Ammonia injection. The 13 N-Ammonia was administered as a single peripheral intravenous bolus (3-5 s) followed by a 10-mL saline flush. Thirty minutes later, a pharmacological stress test was performed, beginning with the injection of adenosine during a 6-minute period (140 mg/kg per minute). A second dose of 740 MBq of 13 N-Ammonia was injected at the third minute of the adenosine infusion. Stress image acquisition was started a few seconds before the radiotracer injection. Sixteen dynamic frames were reconstructed (twelve 10-s, two 30-s, one 1-minute, and one 6-minute frames, for a total of 10 minutes). Standard reconstruction (2D attenuation-weighted ordered subsets expectation maximization) was used with 3 iterations and 14 subsets and 3D postfiltering with a 5-mm Gaussian kernel filter. Transverse data were reformatted to a 168×168×47 matrix with 2 mm pixels for each dynamic frame.
CTA was performed with the 64-slice PET/CT scanner (Biograph True Point; Siemens Medical Solutions) without changing the patient position on the imaging table. Before CT imaging, patients with a heart rate >70 bpm were given metoprolol (≤100 mg oral or 20 mg intravenous in 5-mg increments) to attain a heart rate <70 bpm. A short-acting nitrate (5 mg of isosorbide dinitrate) was given to all patients 2 to 3 minutes before the scan. For CTA, after a timing bolus, ECG-gated helical scanning was performed using ECG-based dose modulation whenever possible, and administration of 60 to 80 mL of Iopamiron 370 (370 mg iodine/mL, rate 5 mL/s, Schering Bayer, Germany) during a 10-s breath-hold. Scan parameters included heart rate-dependent pitch (range, 0.18-0.2), 330-ms gantry rotation time, 120 kVp tube voltage, and tube current time product ranging between 550 and 945 mAs. Filtered backprojection reconstruction of contrast enhanced data was performed at end-systole and in diastole with the use of the following parameters: 0.6-mm slice thickness, 0.3-mm slice increment, 250-mm field of view, 512×512 matrix, and a medium smooth kernel. The cardiac phase with the best image quality was used for further analysis. Reconstructed CTA images were reviewed and analyzed by an expert reader blinded to PET data.
Quantification of MFR by PET
Global and regional myocardial blood flow values in mL/g per minute and MFR values were derived from PET using automated QPET software, as described previously. 15 Left ventricular contours were determined automatically from summed dynamic image data, skipping the first 2 minutes. 15 The region for the left ventricular input function was automatically placed in the middle of the valve plane and was cylindrical with a 1 cm radius and 2 cm length, with its long axis oriented along the long axis of the heart; left ventricular contours and input function placement were reviewed by an expert reader who was blinded to CTA. Dynamic myocardial samples were obtained from the polar map by analyzing all time frames within the fixed left ventricular contour boundaries. Using a standard 2-compartment kinetic model for 13 N-Ammonia, 15, 16 stress and rest flow values in mL/g per minute were computed for each sample on the polar map as previously described. 15 MFR was computed as a ratio by dividing each stress polar map sample by the rest samples at each point. The MFR values were corrected by adjusting the resting flow by the resting pressure product, following standard processing technique, in QPET. The total MFR stress and rest flow was computed within the whole left ventricular region bounded by the left ventricular plane. The regional flow was then obtained by dividing the polar map into 3 regions (left anterior descending artery, left circumflex coronary artery, and right coronary artery) from the standard 17-segment American Heart Association model. Regional and global MFR values were extracted automatically for further analysis. Regional MFR≤2.0 was considered impaired. 
Coronary CTA Analysis
Assessment of multiple plaque characteristics in the coronary arteries was performed with a previously developed automated algorithm (AutoPlaq). Several quantitative measurements were made over each coronary artery up to a normal (reference) arterial diameter limit ≥1.5 mm. 17, 18 To quantify coronary artery segments with any plaque, coronary CTA images were examined in multiplanar format, and proximal and distal limits of the plaque lesions were manually marked by an experienced reader blinded to PET data; plaque lesions with all levels of stenosis were included. Subsequent plaque quantification was fully automated using adaptive algorithms that are scan specific. 17, 18 Quantitative percent stenosis was calculated by dividing the narrowest lumen diameter by the mean of 2 normal nondiseased reference points. The absolute volumes for total plaque, noncalcified plaque, and calcified plaque were computed using scan-specific thresholds, as previously described. 17, 18 Low-density noncalcified plaque was defined as noncalcified plaque below a preset low-density threshold (30 HU). 19 The plaque burden for each of these plaque components was calculated, defined as the plaque volume normalized to the vessel volume (plaque volume×100%/vessel volume). Remodeling index was determined as the ratio of maximum vessel area to that at the proximal normal reference point. 7 Lesion length (in mm) was the length of the diseased vessel as computed in Autoplaq. Contrast density difference over the lesion was computed as follows: the luminal contrast density, defined as attenuation per unit area, similar to area gradient, 20 was computed over 1-mm cross sections of the arterial segment. The contrast density difference was defined as the maximum percent difference in contrast densities, with respect to the proximal reference cross section (with no disease). For each artery, maximum diameter stenosis, remodeling index, and contrast density difference values were reported. The CTA images were evaluated with and without plaque overlay, using transverse and MPR views. In MPR views, longitudinal views and short-axis views of each segment were visually assessed, with and without plaque overlay, as previously described. 18, 21 If the vessel wall needed adjustment, minor edits were made using the automated vessel wall correction options in the software.
Composite Risk Score by Machine Learning
For the composite risk score by machine learning, we used an ensemble-boosting machine-learning algorithm, which is a metaalgorithm technique. In ensemble boosting, a high performance of classification is obtained by combining individual classifiers, resulting in a strong ensemble classification scheme by iteratively adjusting appropriate weights for each of the base-level classifiers. For the current analysis, we used the LogitBoost method, 22 which has been shown to be superior to the other methods, such as AdaBoost, [23] [24] [25] and has been successfully applied previously to a variety of classification schemes, including improvement of the diagnostic accuracy of myocardial perfusion single photon emission computed tomography (SPECT). 26 Patient age, sex, quantitative plaque features (maximum stenosis, noncalcified, low-density noncalcified plaque burden, total lesion length, and contrast density difference), and estimated myocardial mass were combined by machine learning into a composite risk score to predict regional impaired arterial MFR (MFR≤2.0 by PET) within the Waikato Environment for Knowledge Analysis (WEKA) environment. 27 Myocardial mass was estimated from multiplying measured myocardial volume with myocardial density (1.05 g/mL). Ten-fold stratified cross-validation technique was applied to ensure that none of the arteries to create the machine learning model was used in subsequent evaluation of the same model for the prediction of impaired MFR. The machine-learning score was thus validated on unseen data using standard 10-fold cross-validation. Ten-fold cross-validation has been shown to have smaller bias for discriminant analysis than traditional split-sample approach (test and validation) 28 and is currently the preferred technique in data mining. 27 Following 10-fold cross-validation, the final continuous risk scores representing the probability of impaired MFR were derived per vessel. 27 In our implementation of the 10-fold cross-validation (which was used both for the machine-learning composite score and logistic regression), the arteries were always clustered at the patient level, thus in each fold of the cross-validation, there was no patient data where one artery belongs to the training set and the other artery of the same patient to the validation set. This was done to ensure the real-life test of the application, where the method is tested always in new patients and no single patient is used in the training and validation at the same time. For per-patient analysis for the machine-learning score, we applied the maximum composite risk score, similar to maximum diameter stenosis, which has been previously used.
Statistical Analysis
Statistical analyses were performed with STATA software (version 11 StataCorp LP). For all continuous variables, the Shapiro-Wilk test was used to assess normality. All continuous variables were described as mean±SD or median and interquartile range. Two-sample t tests (or Wilcoxon rank-sum test) were used to compare groups regarding continuous variables, whereas Pearson χ 2 or Fisher exact test was used to compare groups regarding categorical variables. Because 3 coronary arteries were examined per patient, the intraclass coefficient was calculated to determine the design effect and the need to adjust these data for clustering, as in a previous study. 29 For any logistic regression, the data from 3 coronary arteries were grouped by clustering. This takes into account that the observations may be dependent within each patient and specifies that the standard errors allow for intragroup correlation. 30, 31 This method has been previously used to group data from 3 vessels. 29 Furthermore, in our study, 10-fold cross-validation was used for all logistic regression, as previously described for machine learning. For multivariable logistic regression analysis, quantitative CTA measures were not normally distributed and required transformation to logarithmic scale. A P value of <0.05 was considered statistically significant, and all tests were 2-sided. Receiver operating characteristic area under the curve comparisons were done based on the methods of DeLong et al. 32 
Results
Median patient age was 61 years (range, 42-85). Demographic and clinical characteristics are listed in Table 1 . Nineteen of 51 patients (37%) had impaired regional MFR in at least 1 territory, in a total of 41 of 153 vessels. There was no difference in any patient characteristics in the impaired MFR versus normal MFR group, except higher patient age for impaired MFR (66.6±8.9 versus 59.3±8.2 years; P=0.008). Thirty-one patients had stress flows <2.0 mL/g per minute, in a total of 66 vessels. There were 30 vessels with epicardial narrowing of 50% or greater, however, MFR was impaired in only 14 of these vessels. Regional perfusion defects (defined as regional ischemic total perfusion defect ≥3% 33 ) were present in 29 vessels in 21 patients. Table 2 shows the stress and rest myocardial blood flow in all patients and in patients with impaired and normal MFR. (Table 3) . Patients with significant stenosis had higher frequencies of impaired MFR (14% versus 34%; P=0.006) and stress flow values <2.0 mL/g per minute (4% versus 34%; P<0.001).
Arteries with impaired MFR displayed significantly higher total plaque burden (37.0% versus 19.3%; P=0.007). Similarly, noncalcified plaque and low-density noncalcified plaque burden were significantly higher in vessels with impaired MFR (Table 3 ). Furthermore, contrast density difference was Figure 1 . Case example from our study: for a 50-year-old male patient with multiple risk factors, including diabetes mellitus, hypertension, and family history. Top row shows right coronary artery segment (RCA) with noncalcified plaque (NCP) in red overlay and calcified plaque (CP) in yellow overlay. Bottom row shows impaired regional myocardial flow reserve (MFR; 1.55 for the RCA territory). Per-vessel NCP and CP volumes were 1331 and 411 mm3 in left anterior descending artery, 305 and 50 mm3 in the left circumflex, and 613 and 11 mm3 in the RCA. Figure 1 shows a case example from our study for a patient with impaired MFR in the right coronary artery. Table 4 shows univariate prediction of impaired MFR by the quantitative per-vessel adverse plaque features. Total number of risk factors and calcified plaque burden were not predictors of impaired MFR. In multivariable analysis with stenosis and noncalcified plaque burden, lesion length, adjusted by age and gender, and with clustering of 3 coronary arteries for each patient, 29 noncalcified plaque burden was the most significant predictor of coronary vascular dysfunction (odds ratio, 1.35; P=0.021; Table 5 ). Using stepwise logistic regression, when noncalcified plaque was included in the model, quantitative stenosis and lesion length were not significant by multivariable analysis (P=0.77 and P=0.96 respectively). Table 6 shows the Spearman rank correlation of pervessel quantitative plaque features with continuous values of regional MFR and stress myocardial blood flow. As seen in Table 6 , plaque burden measures (noncalcified, low-density noncalcified, calcified, and total plaque burden) showed significant negative correlation with MFR and stress myocardial blood flow. As well, stenosis, contrast density difference, and lesion length measures show significant negative correlations with MFR and stress myocardial blood flow. Figure 2 shows the receiver operating characteristic curves for maximal stenosis and the composite score from combining quantitative stenosis and plaque parameters (after 10-fold crossvalidation). As seen in Figure 3 , there was a significant increase in area under the curve for the composite score when compared with maximal stenosis (0.83 [95% confidence interval, 0.79-0.91] versus 0.66 [95% confidence interval, 0.57-0.76]; P=0.005). In per-patient analysis, the area under the curve was 0.93 (95% confidence interval, 0.86-1.00) significantly higher than maximum diameter stenosis (0.69, 95% confidence interval, 0.53-0.84), P=0.0016 (Figure 3) . At a per-patient composite score threshold of 0.28, determined by the optimal Youden's J-statistic, 34 the accuracy, sensitivity, and specificity to determine impaired MFR were 86.3%, 84.2%, and 87.5% respectively.
Composite Risk Score From Quantitative CTA
Discussion
Our results show that automatically measured noncalcified plaque burden in the coronary artery significantly improves prediction of impaired MFR in the corresponding coronary artery territory. Noncalcified plaque burden was the most significant predictor of impaired regional MFR by multivariable analysis. In addition, we showed that an objective score by combining age, sex, stenosis, and characterized arterial plaque burden can significantly improve prediction of impaired MFR measured by 13 N-Ammonia PET.
Impaired MFR, a noninvasive measure of coronary vascular dysfunction, is an early manifestation of coronary artery disease; its prognostic significance has been well-documented. [11] [12] [13] Recent studies have further shown that in symptomatic patients with normal myocardial perfusion imaging by 82 Rb PET, impaired MFR but not the coronary artery calcium score provides significant incremental risk stratification over clinical risk score for prediction of major adverse cardiac events 35 and that in this patient population, coronary vascular dysfunction predicts adverse outcomes regardless of sex. 36 In a study of 107 patients undergoing PET with 15O-water and coronary CTA and subsequently invasive coronary angiography with fractional flow reserve. Kajander et al 37 have shown that obstructive stenosis detected by CTA was suboptimal in assessing stenosis severity, and hybrid PET/CT improved detection of coronary artery disease; in that study, plaque characteristics were not assessed or measured. A previous investigation by Naya et al 38 has evaluated the relationship of visually assessed total coronary plaque burden and composition from CTA with impaired regional MFR measured by 82 Rb PET in 73 consecutive patients. In that study, on a per-vessel basis, maximum diameter stenosis and summed stenosis score were the best predictors of regional impaired myocardial flow reserve. On a per-patient basis, a modified Duke CAD index integrating the site and severity of coronary stenosis and number of coronary segments with mixed plaque were associated with decreased MFR. As discussed by the authors, the latter finding suggested that noncalcified plaques may be as a surrogate marker of more diffuse coronary microvascular dysfunction 38 ; however, quantitative noncalcified or total plaque burden was not measured in that study. The results of our study are also in line with prior studies investigating the relationship of CTA plaque characteristics with ischemia by PET and SPECT. A study by Shmilovich et al 33 Plaque and Impaired Myocardial Flow Reserve myocardial perfusion imaging. Plaques with both low attenuation and positive remodeling were significantly more likely to be associated with ischemia compared with plaques without these features. 33 In a recent study, in 56 lesions of intermediate stenosis by CTA for consecutive patients who subsequently underwent invasive coronary angiography with fractional flow reserve assessment, automatically quantified total and noncalcified plaque burden significantly improved prediction of lesion-specific ischemia by fractional flow reserve compared with luminal stenosis. 39 Our study with quantitative analysis of both CTA and PET is unique because it investigates the relationship of quantitative plaque measures with impaired MFR by 13 N-Ammonia PET, which has not been reported before. Furthermore, our work adds to these studies by inclusion of previously not reported quantitative CTA parameters derived from automated measurement, particularly plaque burden and contrast density difference. Our results show, for the first time, that noncalcified plaque burden, a marker of plaque vulnerability from noninvasive CTA, is significantly related to impaired MFR, also known for its prognostic importance.
From a mechanistic point of view, as summarized by Davignon and Ganz, 40 the endothelium and its product nitric oxide are key regulators of vascular health. Flow-mediated and endothelium-dependent release of nitric oxide not only causes epicardial vasodilation but also exerts numerous antiatherosclerotic effects, such as prevention of leukocyte migration and low-density lipoprotein deposition in the subintimal space, prevention of smooth muscle cell proliferation, as well as antioxidative, and anti-inflammatory effects, all of which confer a certain vascular protection. Our finding that noncalcified plaque, a marker of endothelial injury, is an independent predictor of regional microvascular dysfunction, confirms, at least in part, this hypothesis.
Another novel finding of our study is that an objective composite score combining quantitative stenosis and plaque measures from CTA significantly improves prediction of coronary vascular dysfunction. To our knowledge, these results have not been shown before, particularly using 13 N-Ammonia PET as reference standard. It is uncommon for symptomatic patients to undergo both CTA and myocardial perfusion imaging simultaneously; typically either one or the other test is performed, as indicated. Our results show that improved prediction of coronary vascular dysfunction may be possible from objective combination of quantitative stenosis and plaque, from anatomic CTA alone. Such objective scores by machine learning may improve risk prediction for the patient from CTA, without additional imaging or radiation risk. We acknowledge several limitations in our study. A major limitation was that ours was a pilot study of 51 patients with intermediate likelihood of coronary artery disease at a single medical center. Larger studies are therefore necessary to verify the results from this preliminary pilot study. To prevent model overfitting given our sample size, we only included univariate analysis in Tables 1-4 ; furthermore, only 3 covariates are included in the multivariable analysis ( Table 5 ). The small number of patients in our study also did not allow further analysis of vascular territories with and without epicardial narrowing of 50%. Although 10-fold cross-validation was extensively used in our study for validation, our study lacked an external additional validation cohort, which is needed to verify the validity of the current findings in data from other centers.
In this study, we showed that quantitative plaque characteristics and specifically noncalcified plaque burden, expressed as the percent of the volume of the artery containing noncalcified plaque from CTA, have the potential to aid in identifying downstream regional vascular dysfunction. Our study also shows that an objective composite score combining quantitative stenosis and plaque measures from CTA significantly improves identification of downstream regional vascular dysfunction, over measured stenosis.
